209 related articles for article (PubMed ID: 29869584)
1. Hepatitis C antibody reactivity among high-risk rural women: opportunities for services and treatment in the criminal justice system.
Strickland JC; Staton M; Leukefeld CG; Oser CB; Webster JM
Int J Prison Health; 2018 Jun; 14(2):89-100. PubMed ID: 29869584
[TBL] [Abstract][Full Text] [Related]
2. "Seek, test, treat and retain" for hepatitis C in the United States criminal justice system.
Larney S; G Beckwith C; D Zaller N; T Montague B; Rich J
Int J Prison Health; 2014; 10(3):164-71. PubMed ID: 25764176
[TBL] [Abstract][Full Text] [Related]
3. Associations of criminal justice and substance use treatment involvement with HIV/HCV testing and the HIV treatment cascade among people who use drugs in Oakland, California.
Lambdin BH; Kral AH; Comfort M; Lopez AM; Lorvick J
Addict Sci Clin Pract; 2017 Jun; 12(1):13. PubMed ID: 28610602
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C Epidemiology in a Large Urban Jail: A Changing Demographic.
Hoff E; Warden A; Taylor R; Nijhawan AE
Public Health Rep; 2023; 138(2):248-258. PubMed ID: 35238249
[TBL] [Abstract][Full Text] [Related]
5. Drug use, hepatitis C, and service availability: perspectives of incarcerated rural women.
Staton-Tindall M; Webster JM; Oser CB; Havens JR; Leukefeld CG
Soc Work Public Health; 2015; 30(4):385-96. PubMed ID: 25950907
[TBL] [Abstract][Full Text] [Related]
6. Gender-specific participation and outcomes among jail diversion clients with co-occurring substance use and mental health disorders.
Robertson AG; Easter MM; Lin HJ; Khoury D; Pierce J; Swanson J; Swartz M
J Subst Abuse Treat; 2020 Aug; 115():108035. PubMed ID: 32600621
[TBL] [Abstract][Full Text] [Related]
7. The Impact of Medications for Opioid Use Disorder on Hepatitis C Incidence Among Incarcerated Persons: A Systematic Review.
Seval N; Wurcel A; Gunderson CG; Grimshaw A; Springer SA
Infect Dis Clin North Am; 2020 Sep; 34(3):559-584. PubMed ID: 32782102
[TBL] [Abstract][Full Text] [Related]
8. An exploratory study of mental health and HIV risk behavior among drug-using rural women in jail.
Staton-Tindall M; Harp KLH; Minieri A; Oser C; Webster JM; Havens J; Leukefeld C
Psychiatr Rehabil J; 2015 Mar; 38(1):45-54. PubMed ID: 25799305
[TBL] [Abstract][Full Text] [Related]
9. HIV and HCV in U.S. Prisons and Jails: The Correctional Facility as a Bellwether Over Time for the Community's Infections.
Spaulding AC; Anderson EJ; Khan MA; Taborda-Vidarte CA; Phillips JA
AIDS Rev; 2017; 19(3):134-147. PubMed ID: 28926560
[TBL] [Abstract][Full Text] [Related]
10. Drug Use and Incarceration among Rural Appalachian Women: Findings From a Jail Sample.
Staton M; Ciciurkaite G; Oser C; Tillson M; Leukefeld C; Webster JM; Havens JR
Subst Use Misuse; 2018 May; 53(6):931-941. PubMed ID: 29161158
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for prevalent hepatitis C virus-infection among inmates in a state prison system in Mexico.
Belaunzarán-Zamudio PF; Mosqueda-Gomez JL; Macias-Hernandez A; Sierra-Madero JG; Ahmed S; Beyrer C
PLoS One; 2017; 12(6):e0179931. PubMed ID: 28654650
[TBL] [Abstract][Full Text] [Related]
12. Breaking the addictive cycle of the system: improving US criminal justice practices to address substance use disorders.
Kopak AM
Int J Prison Health; 2015; 11(1):4-16. PubMed ID: 25751703
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C Virus Infection in the Dallas County Jail: Implications for Screening, Prevention, and Linkage to Care.
Abe CM; Aguwa M; Zhao M; Sullivan J; Porsa E; Nijhawan AE
Public Health Rep; 2019; 134(6):626-633. PubMed ID: 31530093
[TBL] [Abstract][Full Text] [Related]
14. Exploring nonprescribed use of buprenorphine in the criminal justice system through qualitative interviews among individuals recently released from incarceration.
Monico LB; Gryczynski J; Lee JD; Dusek K; McDonald R; Malone M; Sharma A; Cheng A; DeVeaugh-Geiss A; Chilcoat H
J Subst Abuse Treat; 2021 Apr; 123():108267. PubMed ID: 33612198
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C in Australian prisons: a national needs assessment.
Mina MM; Herawati L; Butler T; Lloyd A
Int J Prison Health; 2016; 12(1):3-16. PubMed ID: 26933988
[TBL] [Abstract][Full Text] [Related]
16. Knowledge, attitudes, and acceptability of direct-acting antiviral hepatitis C treatment among people incarcerated in jail: A qualitative study.
Akiyama MJ; Ross J; Rimawi F; Fox A; Jordan AO; Wiersema J; Litwin AH; Kaba F; MacDonald R
PLoS One; 2020; 15(12):e0242623. PubMed ID: 33264311
[TBL] [Abstract][Full Text] [Related]
17. Five Questions Concerning Managing Hepatitis C in the Justice System: Finding Practical Solutions for Hepatitis C Virus Elimination.
Spaulding AC; Adee MG; Lawrence RT; Chhatwal J; von Oehsen W
Infect Dis Clin North Am; 2018 Jun; 32(2):323-345. PubMed ID: 29778259
[TBL] [Abstract][Full Text] [Related]
18. Forensic assertive community treatment: preventing incarceration of adults with severe mental illness.
Lamberti JS; Weisman R; Faden DI
Psychiatr Serv; 2004 Nov; 55(11):1285-93. PubMed ID: 15534018
[TBL] [Abstract][Full Text] [Related]
19. High prevalence of sexually transmitted and blood-borne infections amongst the inmates of a district jail in Northern India.
Singh S; Prasad R; Mohanty A
Int J STD AIDS; 1999 Jul; 10(7):475-8. PubMed ID: 10454185
[TBL] [Abstract][Full Text] [Related]
20. Assessment of hepatitis C risk factors and infection prevalence in a jail population.
Wenger PJ; Rottnek F; Parker T; Crippin JS
Am J Public Health; 2014 Sep; 104(9):1722-7. PubMed ID: 25033142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
